nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—Sunitinib—MARK2—salivary gland cancer	0.428	0.428	CrCbGaD
Metoclopramide—Sunitinib—DAPK1—salivary gland cancer	0.297	0.297	CrCbGaD
Metoclopramide—Sunitinib—MAP2K2—salivary gland cancer	0.276	0.276	CrCbGaD
